NEW YORK (GenomeWeb) – Roche today announced that its cobas DPX test for parvovirus B19 and hepatitis A virus in human plasma products has received the CE mark.

The cobas DPX assay is a real-time PCR duplex assay for use on the cobas 6800 and 8800 systems that uses nucleic acid amplification testing to detect viruses in blood and plasma products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.